As of Oct 09
| +0.31 / +1.81%|
The 6 analysts offering 12-month price forecasts for Insmed Inc have a median target of 33.50, with a high estimate of 51.00 and a low estimate of 27.00. The median estimate represents a +92.20% increase from the last price of 17.43.
The current consensus among 7 polled investment analysts is to Buy stock in Insmed Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.